Northwestern University
Chicago, Illinois, 60611, United States
NCT Number: NCT04367922
The Positive Affect Regulation sKills (PARK) Course is an online program containing a series of positive emotion skills for individuals experiencing stress and distress as a result of COVID-19 and the return to "normal." The study specifically targets positive emotion, and offers an array of skills in a self-guided online delivery platform, making the program accessible and convenient in confusing and stressful times.
Our main aims are:
Aim 1: To explore the effects of PARK on anxiety, depression, feelings of social isolation, positive affect, and a sense of meaning and purpose.
Aim 2: To test whether age or gender moderate the effects of the program.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Chicago, Illinois, 60611, United States
The goal of the proposed program, PARK, is to reduce feelings of anxiety, depression, and social isolation, as well as increase well-being and a sense of meaning and purpose through the practice of positive emotion skills via a self-guided online platform. We will compare baseline scores on PROMIS measures of Anxiety, Depression, Social Isolation, Meaning and Purpose, and Positive Emotion to scores after completing the online course (approximately 8 weeks later), and again at 6 months post-baseline.
Research will be based in Northwestern's Feinberg School of Medicine through the Department of Medical Social Sciences (MSS), with all study procedures conducted online. Eligibility screening, consent, and assessments will be conducted on REDCap. For the positive skills course (including weekly lessons and daily skills practice) and daily emotion check-ins, consenting participants will receive access to the online PARK platform, hosted by BrightOutcome.
The skills will be delivered over approximately 6 weeks, and individuals can participate from any device and location with internet access.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The skills will be delivered over approximately 6 weeks, and individuals can participate from any device and location with internet access. A week will consist of 1-2 days of didactic material and 5-6 days of real-life skills practice and reporting. Participants cannot skip ahead, and can only progress to the next lesson if they have completed the current one, but they can return to old lessons or exercises if they wish to. Skills include: positive events, capitalizing, gratitude, mindfulness, positive reappraisal, personal strengths, achievable goals, self-compassion.
Time frame: Baseline, 6 weeks, 6 months
Assessed using PROMIS Anxiety (CAT)
Time frame: Baseline, 6 weeks, 6 months
Assessed using PROMIS Depression (CAT)
Time frame: Baseline, 6 weeks, 6 months
Assessed using PROMIS Social Isolation (CAT)
Time frame: Baseline, 6 weeks, 6 months
Assessed using PROMIS Positive Affect (CAT)
Time frame: Baseline, 6 weeks, 6 months
Assessed using PROMIS Meaning and Purpose (CAT)
Northwestern University
Other
A Positive Affect Regulation sKills Intervention to Decrease Stress During a Pandemic: A Single Arm, Non-Randomized Trial of a Public Platform
Acronym: PARK-NU
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04786561
Alzheimer Disease, Anxiety
Tønsberg, Norway
View Trial DetailsNCT05537311
Anxiety, Anxiety Disorders
Lexington, Kentucky, United States
View Trial DetailsNCT05871554
Anxiety, Anxiety Disorders
Regina, Saskatchewan, Canada
View Trial DetailsNCT02041585
Anxiety, Anxiety Disorders
Chicago, Illinois, United States
View Trial Details